Correlating Estrogen Levels and Cognitive Functions in Regularly Menstruating Females of Reproductive Age Group and Post Menopausal Women of North India
,
Abstract
Objective:To correlate serum estrogen levels with cognitive functions calculated objectively as per Mini Mental State Examination (MMSE) in the females in reproductive age group and those attaining menopause.
Materials and methods:This study was conducted in Christian Medical College and Hospital, Ludhiana, Punjab, India. 150 subjects (100 postmenopausal females and 50 regularly menstruating females of the reproductive age group) were included. The cognitive functions of all the females and serum estrogen levels (i.e Estradiol E2) were assessed.
Results:The E2 levels in normal menstruating females were found to be higher (mean = 188.062 pg/ml) as compared to the menopausal females and the difference in E2 levels was found to be significant (p < 0.001). However, the difference in serum estrogen levels of subjects in the two menopausal groups was insignificant. MMSE, showed that scores of normal menstruating females were higher (mean score = 29.92) as compared to post menopausal females for 1-5 years (mean score = 26.72) and post menopausal females for last 6-10 years (mean score = 26.30).
Conclusion:We observed that the cognition functions declined in post menopausal women, whereas the scores were higher in the women of reproductive age group, meaning thereby, that it is the serum estrogen level that is bringing about this difference. Another finding was that the decline in cognition following menopause was not progressive. Therefore, this correlation would open up the gates for the use of estrogen therapy for various neuropsychological disorders pertaining to cognition in the postmenopausal females.
Guyton AC, Hall JE. Contributions of the cerebellum and basal ganglia to overall motor control. In: Guyton AC, Hall JE. Text book of medical physiology 11th ed. Philadelphia: Elsevier Saunders; 2006: 698-713.
Guyton AC, Hall JE. Cerebral cortex, intellectual function of the brain, learning and memory. In: Guyton AC, Hall JE. Text book of medical physiology 11th ed. Philadelphia: Elsevier Saunders; 2006: 714–27.
Shepherd JE. Effects of estrogen on congnition, mood and degenerative brain diseases. J Am Pharm Assoc (Wash) 2001; 41: 221-8.
Maki PM, Zonderman AB, Resnick SM. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 2001; 158: 227-33.
Ryan J, Carriere I, Scali J, Dartigues JF, Tzourio C, Poncet M, et al. Characteristics of hormone therapy, cognitive function, and dementia: the Prospective 3C study. Neurology 2009; 73: 1729-37.
Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2663-72.
Geerlings MI, Launer LJ, de Jong FH, Ruitenberg A, Stijnen T, van Swieten JC, et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam study. Ann Neurol2003; 53: 607-15.
Luetters C, Huang MH, Seeman T, Buckwalter G, Meyer PM, Avis NE, et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross- ectional results from the Study of Women’s health Across the Nation (SWAN). J Womens Health (Larchmt) 2007; 16: 331-44.
Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 2003; 60: 1369-71.
Sadock BJ, Sadock VA. Kaplan and Sadock’s synopsis of psychiatry: behavioural sciences/clinical psychiatry. 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2003.
Wechsler D. WMS-R manual. New York: Psychological Corporation, 1987.
Reitan R, Davidson L, eds. Clinical neuropsychology, current status and applications. New York: John Wiley, 1974.
Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 958;8:271-6.
Bird TD, Miller BL. Alzheimer’s disease and other dementias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison’s principles of internal medicine. 16th ed. Vol. II. USA: McGraw Hill, 2005: 2393-406.
Maki PM, Gast MJ, Vieweg AJ, Burriss SW, Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007; 69: 1322-30.
Yaffe K, Lui LY, Grady D, Cauley J, Kramer J, Cummings SR. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 2000; 356: 708-12.
Rice MM, Graves AB, McCurry SM, Gibbons LE, Bowen JD, McCormick WC, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame Project. Arch Intern Med 2000; 160: 1641-9.
Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, et al. Hormone replacement therapy and incidence of Alzheimer’s disease in older women: the Cache County study. JAMA 2002; 288: 2123-9.
Laughlin GA, Kritz-Silverstein D, Barrett-Connor E. Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study. Clin Endocrinol (Oxf) 2010; 72: 99-106.
Rosselli M, Tappen R, Williams C, Salvatierra J. The relation of education and gender on the attention items of the Mini-Mental State Examination in Spanish speaking Hispanic elders. Arch ClinNeuropsychol 2006; 21: 677-86.
Lebrun CE, van der Schouw YT, de Jong FH, Pols HA, Grobbee DE, Lamberts SW. Endogenous oestrogens are related to cognition in healthy elderly women. Clin Endocrinol (Oxf) 2005; 63: 50-5.
| Files | ||
| Issue | Vol 9, No 2 (June 2015) | |
| Section | Original Articles | |
| Keywords | ||
| Mini-Mental State Examination and serum estrogen cognitive function post menopausal women | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
